NSPR
InspireMD·NASDAQ
--
--(--)
--
--(--)
NSPR fundamentals
InspireMD (NSPR) Revenue Breakdown: Q3 2025 Business & Regional Performance
InspireMD (NSPR) reported total revenue of 2.52M USD in Q3 2025, with its core business segment Carotid Product contributing 100.00%. Regionally, United States remained the largest market, accounting for 19.70% of total revenue. Explore InspireMD's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
InspireMD (NSPR) reported total revenue of 2.52M USD in Q3 2025, with its core business segment Carotid Product contributing 100.00%. Regionally, United States remained the largest market, accounting for 19.70% of total revenue. Explore InspireMD's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is InspireMD's gross profit margin?What factors drove the changes in InspireMD's revenue and profit?What is the revenue and EPS growth rate for InspireMD year over year?What is the market's earnings forecast for InspireMD next quarter?What were the key takeaways from InspireMD's earnings call?What does InspireMD do and what are its main business segments?Did InspireMD beat or miss consensus estimates last quarter?What guidance did InspireMD's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
